Senior insider sale
IGC PHARMA, INC. — senior position signals high conviction
$78.2K
200K shares
What this filing means
PRINS RICHARD K plans to sell 200K shares of IGC PHARMA, INC. valued at approximately $78.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/9/2024ACC: 0001185185-24-000774
200K
Shares to sell
$78.2K
Approx. market value
300K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Award
Equity Compensation Grants
1/11/2021
300KTotal acquired300K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/11/2021 | Restricted Stock Award Equity Compensation Grants | 300K | — |
| Total | 300K | ||
Planned & Completed Dispositions1
NYSE AMERICANPlanned
Units to sell
200K
Market value
$78.2K
8/12/2024
Total
Units
200K
Value
$78.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/12/2024 | 200K | $78.2K | NYSE AMERICAN | Planned |
| Total | 200K | $78.2K | ||